Skip to content

Reliability of Kinovea in Gait Assessment in Multiple Sclerosis: a Pilot Study.

Reliability of the Kinovea System in the Study of Spatiotemporal Gait Parameters in Multiple Sclerosis: a Pilot Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06928194
Acronym
KV-MS
Enrollment
24
Registered
2025-04-15
Start date
2025-03-10
Completion date
2025-04-02
Last updated
2025-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait Disorders, Neurologic, Multiple Sclerosis

Keywords

Multiple Sclerosis, Gait Disorders, Neurologic, Kinovea, GAITRite

Brief summary

The objective of this observational study is to determine whether the Kinovea video analysis tool is valid and reliable for analyzing spatiotemporal gait parameters in multiple sclerosis, comparing the data obtained from this system with those of the gold standard, the GaitRite system. The main question to be answered is: Is the Kinovea system valid and reliable for analyzing spatiotemporal gait parameters in multiple sclerosis? Participants walked across the GAITRite platform four times without shoes and four times with shoes, while being recorded by two cameras simultaneously: one recorded gait from the sagittal plane and the other from the frontal plane.

Interventions

None listed

Sponsors

Hospital Universitario Virgen Macarena
CollaboratorOTHER
University of Cadiz
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for evaluation by the NeuroLab-Lázaro gait laboratory (Seville). * Patients who have signed informed consent prior to the test. * Patients between 18 and 55 years of age, diagnosed with MS according to the 2017 McDonald criteria. * Patients with an EDSS score of less than 6.5 points. * Patients who are willing to participate in the study and who do not object to being recorded while performing the gait test and to the use of images for educational and research purposes.

Exclusion criteria

* Patients who use walking aids and/or orthoses. * Patients with comorbidity or decompensated systemic disease within the last month. * Patients who have any physical impediment (excessive fatigue) to performing the gait test, as documented in their medical records reviewed on the Diraya platform. * Patients who have suffered a relapse within 30 days prior to the start of the study.

Design outcomes

Primary

MeasureTime frameDescription
Step length (cm)With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.Distance between the two heel strike points during initial contact of opposing feet.
Stride length (cm)With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.Distance between the two heel strike points during initial contact of the same foot. Two step lengths add up to one stride length.
Support base (cm)With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.Distance between the midpoints of the heels of two consecutive steps
Cadence (steps/min)With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.Number of steps taken during a given period
Walking speed (cm/s)With the GAITRite system, measurement is instantaneous, while with the Kinovea system, measurement of all parameters took 2 hours for each patient.Time taken to walk a known distance

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026